Clinical trial · Interventional
Effect of Ultrasound Acupoints on Patients With Polycystic Ovary Syndrome
NCT06844903CI-TRIAL-00091707completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will be conducted to evaluate the effect of ultrasound acupoints on menstrual irregularity and hormone levels on polycystic ovary syndrome (PCOS) patient.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Placebo ultrasound at acupuncture points | Other | — | UNRESOLVED |
| Pulsed ultrasound at acupuncture points | Other | — | UNRESOLVED |
| Standard care program | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Pulsed ultrasound at acupuncture points + Standard care program
- description
- It will consist of 22 patients, who will receive pulsed therapeutic ultrasound (1 MHz) at bilateral acupuncture points of St29, Sp6,and unilateral acupuncture points of Ren4, Ren5, in addition to standard care program.
- interventionNames
- Other: Pulsed ultrasound at acupuncture points
- Other: Standard care program
- type
- PLACEBO_COMPARATOR
- label
- Placebo ultrasound + Standard care program
- description
- It will consist of 22 patients, who will receive placebo therapeutic ultrasound in addition to standard care program.
- interventionNames
- Other: Placebo ultrasound at acupuncture points
- Other: Standard care program
Primary outcomes (4)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 35 Years
Show eligibility criteria text
Inclusion Criteria: * Adults range between 18 and 35 years. * All patients will be stopped drugs that affect the result during study period. * body mass index (BMI) not exceeding 30 kg/m2. * have the symptoms of oligomenorrhea or amenorrhea (appendix I). * No documented or observable psychiatric or neurological disorders that would interfere with study participation (eg, dementia or psychosis). * Not having any type of cancer. Exclusion Criteria: * Any malignancy * Patients with severe or unstable cardiorespiratory or musculoskeletal diseases that may influence the accuracy of quantitative sensory testing results. * Participants who refuse to stop the drugs that affect the study during study period. * Contraindications to therapeutic ultrasound including active cancer in region of hands or feet, presence of deep vein thrombosis, complete numbness in hands or feet, metal or plastic implantation.
References
Publications (0)
Data not yet available
No reference posted for this study.